A method for implementing the American Association of Physicists in Medicine Task Group-43 dosimetry recommendations for 125I transperineal prostate seed implants on commercial treatment planning systems

International Journal of Radiation Oncology Biology Physics

Volumn 37, Issue 3, 1997, Pages 737-741

  Luse, Ray W ^a   Blasko, John ^b   Grimm, Peter ^b  

^a Deaconess Medical Center Spokane   (United States)

^b Northwest Tumor Institute   (United States)

Author keywords

125I; Interstitial brachytherapy; Low dose rate; Treatment planning

Indexed keywords

IODINE 125;

ARTICLE; BRACHYTHERAPY; CALCULATION; CONTROLLED STUDY; DOSIMETRY; HUMAN; INTERSTITIAL RADIATION; MEDICAL SOCIETY; PRIORITY JOURNAL; PROSTATE; TREATMENT PLANNING;

EID: 0030988108     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(96)00576-7     Document Type: Article

References (11)

1. Anderson, L. L.; Nath, R.; Weaver, K. A. (ICWG), Interstitial brachytherapy: Physical, biological, and clinical considerations. New York: Raven; 1990.
2. Blasko, J. C.; Wallner, K.; Grimm, P.; Ragde, H Prostate specific antigen based disease control following I-125 implantation for Stage T1/T2 prostatic carcinoma. J. Urol. 154:1096-1099; 1995.
3. Kaye, K. W.; Olson, D. J.; Payne, J. T. Detailed preliminary analysis of 125 iodine implantation for localized prostate cancer using percutaneous approach. J. Urol. 153:1020-1025; 1995.
4. King, R. P. Physics note, Prowess Users Manual-Version 3000 (1994).
5. Ling, C. C.; Yorke, E. D.; Spiro, I.; Kubiatowitz, D.; Bennett, D Physical dosimetry of I-125 seeds for interstitial implant in advances in radiation therapy. Wright, A. E.; Boyer, A. L., eds. Med. Phys. Monogr. 9:560-574; 1983.
6. Ling, C. C.; Yorke, E. D.; Spiro, I.; Kubiatowitz, D.; Bennett, D Physical dosimetry of I-125 seeds of a new design for interstitial implant. Int. J. Radiat. Oncol. Biol. Phys. 9:1747-1752; 1983.
7. Meigooni, A.; Sabnis, S.; Nath, R Dosimetry of palladium-103 brachytherapy sources for prostate implants. Endocurie-Hypotherm. Oncol. 6:107-117; 1990.
8. National Council on Radiation Protection, (NCRP). Specification of gamma ray brachytherapy sources, NCRP report #41. Washington, DC: U.S. Government Printing Office; 1974.
9. Nath, R.; Anderson, L. L.; Luxton, G.; Weaver, K. A.; Meigooni, A. Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation therapy Committee Task Group No. 43. Med. Phys. 22:209-234; 1995.
10. Stock, R. G.; Stone, N. N.; Wesson, M. F.; DeWyngaert, J. K. A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantation. Int. J. Radiat. Oncol. Biol. Phys. 32:219-225; 1995.
11. Wallner, K.; Roy, J.; Harrison, L. Dosimetry to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 32:465-471; 1995.